The effect of empagliflozin on the development of chronic heart failure after myocardial infarction according to a 12-month prospective study

BACKGROUND: Although the positive cardiovascular effect of empagliflozin has been established, its influence on the formation of heart failure (HF) in patients with type 2 diabetes mellitus (T2D) after myocardial infarction (MI) remains unknown. AIM: To study the effect of empagliflozin on the form...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexey A. Nekrasov, Elena S. Timoschenko, Leonid G. Strongin, Tatyana A. Nekrasova, Anastasiya A. Baranova, Svetlana N. Botova, Michail V. Timoschenko, Mariya A. Yaroslavtseva
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2019
Materias:
Acceso en línea:https://doaj.org/article/444a2d0105754863905b7b402497325b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!